| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.64e-04 | 20 | 108 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | small GTPase binding | 3.57e-04 | 321 | 108 | 8 | GO:0031267 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DOCK4 RANBP2 RGPD8 RAPGEF4 OBSCN ARHGAP35 TBC1D1 FARP1 THG1L RGPD5 | 4.27e-04 | 507 | 108 | 10 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DOCK4 RANBP2 RGPD8 RAPGEF4 OBSCN ARHGAP35 TBC1D1 FARP1 THG1L RGPD5 | 4.27e-04 | 507 | 108 | 10 | GO:0030695 |
| GeneOntologyMolecularFunction | cadherin binding | 5.13e-04 | 339 | 108 | 8 | GO:0045296 | |
| GeneOntologyMolecularFunction | GTPase binding | 7.60e-04 | 360 | 108 | 8 | GO:0051020 | |
| GeneOntologyCellularComponent | nuclear envelope | RANBP2 RGPD8 POLA1 INTS1 APC XPO4 PTGS2 WDR3 OIT3 SYNE2 CST3 ZBED1 RGPD5 | 6.41e-06 | 560 | 108 | 13 | GO:0005635 |
| GeneOntologyCellularComponent | nuclear membrane | 8.33e-05 | 349 | 108 | 9 | GO:0031965 | |
| GeneOntologyCellularComponent | Pwp2p-containing subcomplex of 90S preribosome | 3.91e-04 | 6 | 108 | 2 | GO:0034388 | |
| GeneOntologyCellularComponent | 90S preribosome | 4.44e-04 | 29 | 108 | 3 | GO:0030686 | |
| GeneOntologyCellularComponent | PTW/PP1 phosphatase complex | 5.46e-04 | 7 | 108 | 2 | GO:0072357 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RANBP2 ERCC4 WDR36 WWOX RGPD8 POLA1 SMARCAL1 INTS1 XPO4 API5 WDR3 SUPT6H SYNE2 NCOA1 WDR12 MGA RGPD5 | 6.81e-04 | 1377 | 108 | 17 | GO:0140513 |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 7.26e-04 | 8 | 108 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | organelle envelope | RANBP2 RGPD8 POLA1 INTS1 APC XPO4 PTGS2 PPP1CC WDR3 OIT3 TMEM70 SYNE2 THG1L CST3 RARS2 ZBED1 RGPD5 | 1.08e-03 | 1435 | 108 | 17 | GO:0031967 |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.16e-03 | 10 | 108 | 2 | GO:0044614 | |
| MousePheno | abnormal cell nucleus morphology | 1.57e-05 | 184 | 85 | 8 | MP:0003111 | |
| MousePheno | aneuploidy | 3.36e-05 | 61 | 85 | 5 | MP:0004024 | |
| MousePheno | increased sarcoma incidence | 3.57e-05 | 102 | 85 | 6 | MP:0002032 | |
| MousePheno | increased hepatocellular carcinoma incidence | 6.55e-05 | 70 | 85 | 5 | MP:0003331 | |
| MousePheno | abnormal intracellular organelle morphology | PDS5B RANBP2 ERCC4 RGPD8 STAG1 APC EPG5 TMEM70 SYNE2 ATM CAMSAP1 CLUH | 1.09e-04 | 546 | 85 | 12 | MP:0014239 |
| MousePheno | abnormal chromosome morphology | 1.16e-04 | 126 | 85 | 6 | MP:0003702 | |
| Domain | DM15 | 3.07e-05 | 2 | 104 | 2 | SM00684 | |
| Domain | DM15 | 3.07e-05 | 2 | 104 | 2 | IPR006607 | |
| Domain | Ran_BP1 | 3.56e-05 | 12 | 104 | 3 | PF00638 | |
| Domain | RANBD1 | 3.56e-05 | 12 | 104 | 3 | PS50196 | |
| Domain | RanBD | 4.61e-05 | 13 | 104 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 4.61e-05 | 13 | 104 | 3 | IPR000156 | |
| Domain | STPPase_N | 9.18e-05 | 3 | 104 | 2 | IPR031675 | |
| Domain | STPPase_N | 9.18e-05 | 3 | 104 | 2 | PF16891 | |
| Domain | - | 4.45e-04 | 27 | 104 | 3 | 1.10.260.40 | |
| Domain | Lambda_DNA-bd_dom | 5.52e-04 | 29 | 104 | 3 | IPR010982 | |
| Domain | RNaseH-like_dom | 5.94e-04 | 69 | 104 | 4 | IPR012337 | |
| Domain | ARM-type_fold | 6.16e-04 | 339 | 104 | 8 | IPR016024 | |
| Domain | LA | 6.33e-04 | 7 | 104 | 2 | SM00715 | |
| Domain | CUT | 6.33e-04 | 7 | 104 | 2 | PS51042 | |
| Domain | CUT | 6.33e-04 | 7 | 104 | 2 | PF02376 | |
| Domain | HTH_LA | 6.33e-04 | 7 | 104 | 2 | PS50961 | |
| Domain | La | 6.33e-04 | 7 | 104 | 2 | PF05383 | |
| Domain | CUT_dom | 6.33e-04 | 7 | 104 | 2 | IPR003350 | |
| Domain | Lupus_La_RNA-bd | 6.33e-04 | 7 | 104 | 2 | IPR006630 | |
| Domain | CUT | 6.33e-04 | 7 | 104 | 2 | SM01109 | |
| Domain | RuvA_2-like | 1.08e-03 | 9 | 104 | 2 | IPR010994 | |
| Domain | Grip | 1.63e-03 | 11 | 104 | 2 | SM00755 | |
| Domain | GRIP | 1.63e-03 | 11 | 104 | 2 | PF01465 | |
| Domain | GRIP_dom | 1.95e-03 | 12 | 104 | 2 | IPR000237 | |
| Domain | GRIP | 1.95e-03 | 12 | 104 | 2 | PS50913 | |
| Domain | PP2Ac | 2.30e-03 | 13 | 104 | 2 | SM00156 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 2.30e-03 | 13 | 104 | 2 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 2.30e-03 | 13 | 104 | 2 | PS00125 | |
| Domain | Beta/gamma_crystallin | 3.08e-03 | 15 | 104 | 2 | IPR001064 | |
| Domain | CRYSTALLIN_BETA_GAMMA | 3.08e-03 | 15 | 104 | 2 | PS50915 | |
| Domain | Crystall | 3.08e-03 | 15 | 104 | 2 | PF00030 | |
| Domain | XTALbg | 3.08e-03 | 15 | 104 | 2 | SM00247 | |
| Domain | G_crystallin-rel | 4.43e-03 | 18 | 104 | 2 | IPR011024 | |
| Domain | Apc4_WD40_dom | 5.47e-03 | 20 | 104 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 5.47e-03 | 20 | 104 | 2 | PF12894 | |
| Pubmed | PDS5B RANBP2 WDR36 MYO1D USP11 POLA1 INTS1 LARP1 PPP1CA PPP1CC WDR3 SUPT6H SYNE2 WDR12 ATM CLUH | 2.05e-10 | 653 | 108 | 16 | 22586326 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RANBP2 MYO1D RBM33 POLA1 APC LARP1 HMMR LARP1B ARHGAP35 PPP1CA PPP1CC FARP1 CAMSAP1 MGA CLUH | 7.57e-09 | 724 | 108 | 15 | 36232890 |
| Pubmed | 1.16e-07 | 4 | 108 | 3 | 9480752 | ||
| Pubmed | DOCK4 NRG1 POLA1 INTS1 APC ARHGAP35 CIC TBC1D1 ZNF483 EIF4G2 WDR12 MGA CLUH | 2.38e-07 | 689 | 108 | 13 | 36543142 | |
| Pubmed | RANBP2 USP11 OBSCN FSD2 CMYA5 PPP1CC SUPT6H SYNE2 EIF4G2 DNAJB5 MGA | 4.51e-07 | 497 | 108 | 11 | 23414517 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DOCK4 GRK7 APC LARP1 LARP1B PRAG1 CIC PPP1CA RUSC2 TBC1D1 SYNE2 CRYBG3 CAMSAP1 PCDH7 | 4.75e-07 | 861 | 108 | 14 | 36931259 |
| Pubmed | WDR36 USP11 HMMR PPP1CC WDR3 SUPT6H MAP4K5 FARP1 SYNE2 EIF4G2 WDR12 ATM CRYBG3 DNAJB5 NME7 PCDH7 CLUH CUX1 | 7.40e-07 | 1487 | 108 | 18 | 33957083 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PDS5B RANBP2 WDR36 WWOX RBM33 LARP1 POU4F3 API5 CIC PPP1CC WDR3 EIF4G2 MGA CUX1 | 1.59e-06 | 954 | 108 | 14 | 36373674 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDS5B RANBP2 WDR36 MYO1D POLA1 TRPC1 LARP1 API5 IDH3B CMYA5 PPP1CA WDR3 SUPT6H EIF4G2 WDR12 ATM CLUH | 1.90e-06 | 1425 | 108 | 17 | 30948266 |
| Pubmed | WDR36 STAG1 RBM33 POLA1 HMMR ARHGAP35 CIC CRYBG3 CAMSAP1 CUX1 | 2.28e-06 | 472 | 108 | 10 | 38943005 | |
| Pubmed | STAG1 CILK1 PPL PPP1CA EPG5 PPP1CC TBC1D1 EIF4G2 GMEB1 CAMSAP1 MGA | 2.42e-06 | 591 | 108 | 11 | 15231748 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | WDR36 WWOX RGPD8 MYO1D RBM33 USP11 IDH3B LARP1B WDR3 TMEM70 SYNE2 THG1L RARS2 WDR12 CRYBG3 CLUH CUX1 | 3.64e-06 | 1496 | 108 | 17 | 32877691 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | RANBP2 RGPD8 MYO1D SMARCAL1 LARP1 C4orf54 PPP1CA KRT23 FARP1 CUX1 RGPD5 | 4.19e-06 | 626 | 108 | 11 | 33644029 |
| Pubmed | RANBP2 RBM33 POLA1 API5 IDH3B PPP1CC WDR3 SUPT6H EIF4G2 WDR12 DNAJB5 | 5.02e-06 | 638 | 108 | 11 | 33239621 | |
| Pubmed | 6.58e-06 | 418 | 108 | 9 | 34709266 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 8945508 | ||
| Pubmed | Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. | 9.55e-06 | 2 | 108 | 2 | 8945503 | |
| Pubmed | Ryanodine receptors are part of the myospryn complex in cardiac muscle. | 9.55e-06 | 2 | 108 | 2 | 28740084 | |
| Pubmed | CDP/Cux stimulates transcription from the DNA polymerase alpha gene promoter. | 9.55e-06 | 2 | 108 | 2 | 12665598 | |
| Pubmed | Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice. | 9.55e-06 | 2 | 108 | 2 | 10188882 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 11245490 | ||
| Pubmed | WWOX modulates the ATR-mediated DNA damage checkpoint response. | 9.55e-06 | 2 | 108 | 2 | 26675548 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 10571067 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12151354 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 9882500 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 15150127 | ||
| Pubmed | Correlation between COX-2 and APC expression in left versus right-sided human colon cancer. | 9.55e-06 | 2 | 108 | 2 | 21737640 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 12778076 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 14534534 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 23360427 | ||
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 31521612 | ||
| Pubmed | Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). | 9.55e-06 | 2 | 108 | 2 | 11313976 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 10783317 | ||
| Pubmed | PP-1α and PP-1γ display antagonism and differential roles in tumorigenicity of lung cancer cells. | 9.55e-06 | 2 | 108 | 2 | 23176181 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 17700532 | ||
| Pubmed | Association of GPIa and COX-2 gene polymorphism with aspirin resistance. | 9.55e-06 | 2 | 108 | 2 | 28948649 | |
| Pubmed | 9.55e-06 | 2 | 108 | 2 | 16699180 | ||
| Pubmed | Monoacylglycerol acyltransferase-2 inhibits colorectal carcinogenesis in APCmin+/- mice. | 9.55e-06 | 2 | 108 | 2 | 39055928 | |
| Pubmed | PDS5B RANBP2 RGPD8 MYO1D STAG1 PCDHGB6 LARP1 PPL PPP1CA PPP1CC KRT23 SYNE2 C4orf51 ATM CUX1 RGPD5 | 9.79e-06 | 1442 | 108 | 16 | 35575683 | |
| Pubmed | Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. | 9.88e-06 | 43 | 108 | 4 | 34672947 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 9.91e-06 | 440 | 108 | 9 | 34244565 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DOCK4 RANBP2 MYO1D APC CILK1 WDR3 TBC1D1 FARP1 EIF4G2 CAMSAP1 NME7 MGA | 1.42e-05 | 853 | 108 | 12 | 28718761 |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 1.44e-05 | 583 | 108 | 10 | 29844126 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.55e-05 | 588 | 108 | 10 | 38580884 | |
| Pubmed | RANBP2 WDR36 RBM33 INTS1 APC HMMR API5 CIC PPP1CC WDR3 SUPT6H FARP1 EIF4G2 CRYBG1 WDR12 DUSP11 | 1.55e-05 | 1497 | 108 | 16 | 31527615 | |
| Pubmed | PDS5B RANBP2 WDR36 USP11 POLA1 SMARCAL1 INTS1 API5 PPP1CA WDR3 SUPT6H EIF4G2 ATM | 1.63e-05 | 1014 | 108 | 13 | 32416067 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 1.68e-05 | 258 | 108 | 7 | 37794589 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.59e-05 | 497 | 108 | 9 | 36774506 | |
| Pubmed | Mutually exclusive binding of PP1 and RNA to AKAP149 affects the mitochondrial network. | 2.86e-05 | 3 | 108 | 2 | 19074462 | |
| Pubmed | 1E7-03, a low MW compound targeting host protein phosphatase-1, inhibits HIV-1 transcription. | 2.86e-05 | 3 | 108 | 2 | 25073485 | |
| Pubmed | Alpha2beta1 integrin signalling enhances cyclooxygenase-2 expression in intestinal epithelial cells. | 2.86e-05 | 3 | 108 | 2 | 16972245 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 12138106 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 7857673 | ||
| Pubmed | Dynamic targeting of protein phosphatase 1 within the nuclei of living mammalian cells. | 2.86e-05 | 3 | 108 | 2 | 11739654 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 9882488 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 16630131 | ||
| Pubmed | Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. | 2.86e-05 | 3 | 108 | 2 | 10987272 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 12189188 | ||
| Pubmed | Protein phosphatase 1 (PP1) is a post-translational regulator of the mammalian circadian clock. | 2.86e-05 | 3 | 108 | 2 | 21712997 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 17965019 | ||
| Pubmed | Role of Nesprin-2 and RanBP2 in BICD2-associated brain developmental disorders. | 2.86e-05 | 3 | 108 | 2 | 36930595 | |
| Pubmed | Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms. | 2.86e-05 | 3 | 108 | 2 | 10204802 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 11181458 | ||
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 11588169 | ||
| Pubmed | Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis. | 2.86e-05 | 3 | 108 | 2 | 12941808 | |
| Pubmed | 2.86e-05 | 3 | 108 | 2 | 17546626 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 3.56e-05 | 398 | 108 | 8 | 35016035 | |
| Pubmed | 3.73e-05 | 652 | 108 | 10 | 31180492 | ||
| Pubmed | Network-Based Combinatorial CRISPR-Cas9 Screens Identify Synergistic Modules in Human Cells. | 4.55e-05 | 63 | 108 | 4 | 30762338 | |
| Pubmed | RANBP2 RGPD8 ZNF618 RAPGEF4 APC PPP1CA PPP1CC FARP1 SYNE2 CAMSAP1 MGA CUX1 | 4.63e-05 | 963 | 108 | 12 | 28671696 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | ZFAND2A TRAPPC11 MYO1D USP11 LARP1 PPP1CA PPP1CC SUPT6H TBC1D1 CUX1 | 4.69e-05 | 670 | 108 | 10 | 22990118 |
| Pubmed | 5.04e-05 | 209 | 108 | 6 | 36779422 | ||
| Pubmed | 5.11e-05 | 419 | 108 | 8 | 15635413 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 23499489 | ||
| Pubmed | Nuclear targeting of protein phosphatase-1 by HIV-1 Tat protein. | 5.71e-05 | 4 | 108 | 2 | 16131488 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 20178602 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 15226296 | ||
| Pubmed | Involvement of the telomeric protein Pin2/TRF1 in the regulation of the mitotic spindle. | 5.71e-05 | 4 | 108 | 2 | 11943150 | |
| Pubmed | Nup358 interacts with APC and plays a role in cell polarization. | 5.71e-05 | 4 | 108 | 2 | 19654215 | |
| Pubmed | Nuclear protein phosphatase-1 regulates HIV-1 transcription. | 5.71e-05 | 4 | 108 | 2 | 12788939 | |
| Pubmed | Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx. | 5.71e-05 | 4 | 108 | 2 | 23277204 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 12016225 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 12221103 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 19549529 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 30317028 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 17202132 | ||
| Pubmed | The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2. | 5.71e-05 | 4 | 108 | 2 | 22049153 | |
| Pubmed | ATM regulates ionizing radiation-induced disruption of HDAC1:PP1:Rb complexes. | 5.71e-05 | 4 | 108 | 2 | 17008050 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 24902662 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 19375854 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 10194355 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 25331887 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 10880350 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 22768081 | ||
| Pubmed | DNA methylation markers and early recurrence in stage I lung cancer. | 5.71e-05 | 4 | 108 | 2 | 18337602 | |
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 10807923 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 12226088 | ||
| Pubmed | 5.71e-05 | 4 | 108 | 2 | 12036952 | ||
| Pubmed | N-CoR controls differentiation of neural stem cells into astrocytes. | 5.71e-05 | 4 | 108 | 2 | 12410313 | |
| Pubmed | 7.03e-05 | 222 | 108 | 6 | 37071664 | ||
| Interaction | SIRT7 interactions | PDS5B RANBP2 WDR36 MYO1D USP11 POLA1 INTS1 LARP1 PPP1CA PPP1CC WDR3 SUPT6H SYNE2 WDR12 ATM CLUH | 1.30e-06 | 744 | 104 | 16 | int:SIRT7 |
| Interaction | PCNA interactions | PDS5B RANBP2 WWOX USP11 POLA1 OBSCN APC PPP1CA PPP1CC ATM PCDH7 CUX1 | 9.80e-06 | 497 | 104 | 12 | int:PCNA |
| Interaction | NIN interactions | 1.68e-05 | 359 | 104 | 10 | int:NIN | |
| Interaction | KRT8 interactions | DOCK4 TRAPPC11 APC PPL KRT23 CRYBG1 CRYBG3 CAMSAP1 PCDH7 CLUH CUX1 | 1.74e-05 | 441 | 104 | 11 | int:KRT8 |
| Interaction | NUP43 interactions | PDS5B RANBP2 WDR36 RGPD8 POLA1 APC LARP1 WDR3 SUPT6H SYNE2 EIF4G2 MGA RGPD5 | 1.99e-05 | 625 | 104 | 13 | int:NUP43 |
| Interaction | MLNR interactions | 2.68e-05 | 68 | 104 | 5 | int:MLNR | |
| Interaction | ADGRG2 interactions | 2.84e-05 | 12 | 104 | 3 | int:ADGRG2 | |
| Interaction | NUP50 interactions | 6.86e-05 | 341 | 104 | 9 | int:NUP50 | |
| GeneFamily | Beta-gamma crystallin domain containing | 4.68e-05 | 3 | 72 | 2 | 1360 | |
| GeneFamily | WD repeat domain containing|UTPB complex | 2.32e-04 | 6 | 72 | 2 | 1225 | |
| GeneFamily | La ribonucleoprotein domain containing|RNA binding motif containing | 3.24e-04 | 7 | 72 | 2 | 625 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 5.53e-04 | 9 | 72 | 2 | 527 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 1.19e-03 | 13 | 72 | 2 | 693 | |
| GeneFamily | Fibronectin type III domain containing | 3.81e-03 | 160 | 72 | 4 | 555 | |
| Coexpression | DASU_IL6_SIGNALING_SCAR_UP | 7.87e-06 | 31 | 108 | 4 | M292 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_UP | 8.29e-06 | 175 | 108 | 7 | M8578 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK4 PDS5B NRG1 RANBP2 STAG1 TRPC1 APC HMMR ARHGAP35 MAP4K5 SYNE2 NCOA1 CRYBG3 CUX1 | 1.15e-05 | 856 | 108 | 14 | M4500 |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP | 1.97e-05 | 200 | 108 | 7 | M9205 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP | 1.97e-05 | 200 | 108 | 7 | M6090 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 2.86e-05 | 212 | 108 | 7 | M39221 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | WDR36 STAG1 APC HMMR API5 FADS3 SUPT6H MAP4K5 EIF4G2 RARS2 CAMSAP1 NME7 | 4.29e-05 | 721 | 108 | 12 | M10237 |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-07 | 174 | 108 | 7 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.01e-07 | 181 | 108 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.70e-07 | 199 | 108 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.89e-07 | 200 | 108 | 7 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-06 | 170 | 108 | 6 | 50c6c571591aa4b218caefe5778c570c809f567e | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-06 | 170 | 108 | 6 | 8fe32dcf924d5f6665f7febbc9647d96b1e96f06 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-06 | 170 | 108 | 6 | 3232db50b1a40f861e981a1b9c9073b81af9f832 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.66e-06 | 183 | 108 | 6 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.02e-06 | 185 | 108 | 6 | 847257d232b9993cad50c814fd4ffeef52385295 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.21e-06 | 186 | 108 | 6 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.40e-06 | 187 | 108 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 6.40e-06 | 187 | 108 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.01e-06 | 190 | 108 | 6 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.67e-06 | 193 | 108 | 6 | 01c71aa48875b5ad6c50cc810a72862e72f26ad0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 194 | 108 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 194 | 108 | 6 | b0c15e7e4bcf30856fb628dedd7ba82df33489f5 | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 8.38e-06 | 196 | 108 | 6 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.62e-06 | 197 | 108 | 6 | 789c97ca9d1e28df3353140046047f11fbccc1d0 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.87e-06 | 198 | 108 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 8.87e-06 | 198 | 108 | 6 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.13e-06 | 199 | 108 | 6 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.40e-06 | 200 | 108 | 6 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.18e-05 | 138 | 108 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.42e-05 | 173 | 108 | 5 | 79d11f94a8f6a420c18c2fef0da77e9af3204765 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.60e-05 | 174 | 108 | 5 | bc978a2148a0261a4f9d1ca5479b707e224566be | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.78e-05 | 175 | 108 | 5 | f456d8d958b71f7a942b718605712593d9de1bfd | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.96e-05 | 176 | 108 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.96e-05 | 176 | 108 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.15e-05 | 177 | 108 | 5 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-05 | 179 | 108 | 5 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.54e-05 | 179 | 108 | 5 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.74e-05 | 180 | 108 | 5 | 16728b9a1c52097e3a460534be71a476ecc54f0f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.59e-05 | 184 | 108 | 5 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.59e-05 | 184 | 108 | 5 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 8.59e-05 | 184 | 108 | 5 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | mild-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.59e-05 | 184 | 108 | 5 | 1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.59e-05 | 184 | 108 | 5 | a12a6a481e78adc62da1904431f62b119f70b15f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.81e-05 | 185 | 108 | 5 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 8.81e-05 | 185 | 108 | 5 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 185 | 108 | 5 | efcfbf5a48b3ea9a425183e5c2eec6a9585415a0 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 185 | 108 | 5 | 642088ace9230d38b0579853c54ff4dd8b5d5df4 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 185 | 108 | 5 | dc59b8dc459a3c444c9634a0d438cbef54c40036 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.04e-05 | 186 | 108 | 5 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-05 | 187 | 108 | 5 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-05 | 187 | 108 | 5 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-05 | 187 | 108 | 5 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-05 | 187 | 108 | 5 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.27e-05 | 187 | 108 | 5 | d9d10ed7c905778a29a0dc3ced3eef02a6b1de5c | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.27e-05 | 187 | 108 | 5 | 25efb82afe863a853ecdd781ad89026c993aaa67 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 9.27e-05 | 187 | 108 | 5 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.27e-05 | 187 | 108 | 5 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 9.50e-05 | 188 | 108 | 5 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 9.50e-05 | 188 | 108 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.50e-05 | 188 | 108 | 5 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-05 | 188 | 108 | 5 | 59b71462338a7efbacf46577cb07e9db3363afee | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 9.74e-05 | 189 | 108 | 5 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 9.74e-05 | 189 | 108 | 5 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.74e-05 | 189 | 108 | 5 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.74e-05 | 189 | 108 | 5 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.74e-05 | 189 | 108 | 5 | 1d660bceee449aebf12fc9af4c74af246837b27a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 9.74e-05 | 189 | 108 | 5 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.99e-05 | 190 | 108 | 5 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 9.99e-05 | 190 | 108 | 5 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 9.99e-05 | 190 | 108 | 5 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.99e-05 | 190 | 108 | 5 | 8a53f4d3c9aca45b5826f53f7dcdfb8bc8280acb | |
| ToppCell | T_cells-Effector_memory_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 9.99e-05 | 190 | 108 | 5 | 1af91fe0ee2c924e12f4db93c793e7af475d8f80 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 9.99e-05 | 190 | 108 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.02e-04 | 191 | 108 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 191 | 108 | 5 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-04 | 191 | 108 | 5 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.02e-04 | 191 | 108 | 5 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 1.05e-04 | 192 | 108 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 1.05e-04 | 192 | 108 | 5 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 192 | 108 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.05e-04 | 192 | 108 | 5 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.07e-04 | 193 | 108 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 193 | 108 | 5 | d338a7c0585b69947c37f44aa0381619493e31ea | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 193 | 108 | 5 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-04 | 193 | 108 | 5 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Endometrioid-1|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 1.07e-04 | 193 | 108 | 5 | c2673d86f7d7b849788036032a93a6d136a70040 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.07e-04 | 193 | 108 | 5 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 193 | 108 | 5 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 193 | 108 | 5 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 194 | 108 | 5 | 3c31ac44e8cf4eca3ba7b8bfc05ad3e96a970956 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 194 | 108 | 5 | 74a9fdb73f279bebb6337510deab9aaaf9f7e957 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 194 | 108 | 5 | 32ba2cf9b8726bc3c6e9dc24b54d22ff188bb12b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 194 | 108 | 5 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 194 | 108 | 5 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 194 | 108 | 5 | eb279e0d922de921343f0ae032a809f837d915b3 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 194 | 108 | 5 | 53a5e8863d79a052dff0758f389be5ac3883c721 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 194 | 108 | 5 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 195 | 108 | 5 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.13e-04 | 195 | 108 | 5 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.13e-04 | 195 | 108 | 5 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 196 | 108 | 5 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 196 | 108 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 196 | 108 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | saliva|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.18e-04 | 197 | 108 | 5 | 0a7457dbf798f6071ada3b2b2be231ad13bdb660 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-04 | 197 | 108 | 5 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 197 | 108 | 5 | 0f467ef58f0c4dcc00b34b7b9639e03fb3ebe780 | |
| Drug | Chlorine trioxide | 1.89e-06 | 6 | 105 | 3 | CID000139646 | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 3.57e-06 | 196 | 105 | 8 | 6994_DN | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 4.00e-06 | 199 | 105 | 8 | 3410_DN | |
| Disease | Malignant neoplasm of breast | NRG1 WWOX PCDHGB6 SMARCAL1 OBSCN HMMR PTGS2 CIC EPG5 KCNT2 FARP1 SYNE2 NCOA1 ATM CUX1 | 4.83e-06 | 1074 | 103 | 15 | C0006142 |
| Disease | cancer (implicated_via_orthology) | 4.45e-05 | 268 | 103 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 6.05e-05 | 616 | 103 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 6.05e-05 | 616 | 103 | 10 | C0376358 | |
| Disease | lysophosphatidylcholine measurement | 6.69e-05 | 62 | 103 | 4 | EFO_0010224 | |
| Disease | Liver carcinoma | 7.31e-05 | 507 | 103 | 9 | C2239176 | |
| Disease | Intestinal Polyps | 1.20e-04 | 5 | 103 | 2 | C0021846 | |
| Disease | heart rate | 1.42e-04 | 225 | 103 | 6 | EFO_0004326 | |
| Disease | peripheral neuropathy, response to bortezomib | 1.79e-04 | 6 | 103 | 2 | EFO_0003100, EFO_0007808 | |
| Disease | creatinine measurement | NRG1 STAG1 USP11 GRK7 TRPC1 OBSCN FSD2 PTGS2 MAP4K5 CUX1 CDH13 DUSP11 | 1.85e-04 | 995 | 103 | 12 | EFO_0004518 |
| Disease | Glioma | 2.50e-04 | 87 | 103 | 4 | C0017638 | |
| Disease | urate measurement, bone density | 3.24e-04 | 619 | 103 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | Adenocarcinoma of large intestine | 3.64e-04 | 96 | 103 | 4 | C1319315 | |
| Disease | Bell's palsy | 4.58e-04 | 102 | 103 | 4 | EFO_0007167 | |
| Disease | level of Phosphatidylcholine (18:0_22:5) in blood serum | 5.33e-04 | 10 | 103 | 2 | OBA_2045096 | |
| Disease | level of Ceramide (d40:1) in blood serum | 6.50e-04 | 11 | 103 | 2 | OBA_2045185 | |
| Disease | pancreatic cancer (is_implicated_in) | 6.51e-04 | 112 | 103 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | Fibrosis | 7.19e-04 | 50 | 103 | 3 | C0016059 | |
| Disease | Cirrhosis | 7.19e-04 | 50 | 103 | 3 | C1623038 | |
| Disease | retinal drusen | 7.62e-04 | 51 | 103 | 3 | EFO_1001155 | |
| Disease | endometrial carcinoma (is_implicated_in) | 7.78e-04 | 12 | 103 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | Secondary Open Angle Glaucoma | 7.78e-04 | 12 | 103 | 2 | C0271148 | |
| Disease | Glaucoma, Open-Angle | 7.78e-04 | 12 | 103 | 2 | C0017612 | |
| Disease | substance-related disorder | 8.06e-04 | 52 | 103 | 3 | MONDO_0002494 | |
| Disease | glucose metabolism measurement, age-related hearing impairment | 8.06e-04 | 52 | 103 | 3 | EFO_0005782, EFO_0009367 | |
| Disease | Glaucoma, Primary Open Angle | 9.18e-04 | 13 | 103 | 2 | C0339573 | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 9.18e-04 | 13 | 103 | 2 | OBA_2045072 | |
| Disease | Squamous cell carcinoma | 9.53e-04 | 124 | 103 | 4 | C0007137 | |
| Disease | level of Phosphatidylcholine (18:1_20:2) in blood serum | 1.07e-03 | 14 | 103 | 2 | OBA_2045102 | |
| Disease | Malignant Neoplasms | 1.07e-03 | 128 | 103 | 4 | C0006826 | |
| Disease | schizophrenia (biomarker_via_orthology) | 1.23e-03 | 15 | 103 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | glucose homeostasis measurement, glucose effectiveness measurement | 1.23e-03 | 15 | 103 | 2 | EFO_0006833, EFO_0006896 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 1.37e-03 | 346 | 103 | 6 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | Barrett Epithelium | 1.40e-03 | 16 | 103 | 2 | C1258085 | |
| Disease | Polyposis, Adenomatous Intestinal | 1.40e-03 | 16 | 103 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 1.40e-03 | 16 | 103 | 2 | C2713443 | |
| Disease | Barrett Esophagus | 1.40e-03 | 16 | 103 | 2 | C0004763 | |
| Disease | Benign neoplasm of stomach | 1.59e-03 | 17 | 103 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.59e-03 | 17 | 103 | 2 | C0496905 | |
| Disease | diabetic neuropathy (biomarker_via_orthology) | 1.59e-03 | 17 | 103 | 2 | DOID:9743 (biomarker_via_orthology) | |
| Disease | Carcinoma in situ of stomach | 1.59e-03 | 17 | 103 | 2 | C0154060 | |
| Disease | Alzheimer disease, brain volume measurement | 1.59e-03 | 17 | 103 | 2 | EFO_0006930, MONDO_0004975 | |
| Disease | Adenomatous Polyposis Coli | 1.59e-03 | 17 | 103 | 2 | C0032580 | |
| Disease | obesity | 1.59e-03 | 241 | 103 | 5 | EFO_0001073 | |
| Disease | Oral Submucous Fibrosis | 1.78e-03 | 18 | 103 | 2 | C0029172 | |
| Disease | Gastric ulcer | 1.78e-03 | 18 | 103 | 2 | C0038358 | |
| Disease | melanoma | 1.81e-03 | 248 | 103 | 5 | C0025202 | |
| Disease | JT interval | 1.81e-03 | 248 | 103 | 5 | EFO_0007885 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.83e-03 | 148 | 103 | 4 | C0279702 | |
| Disease | Cardiomyopathies, Primary | 1.83e-03 | 69 | 103 | 3 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 1.83e-03 | 69 | 103 | 3 | C0036529 | |
| Disease | Alzheimer's disease (is_marker_for) | 2.11e-03 | 257 | 103 | 5 | DOID:10652 (is_marker_for) | |
| Disease | nucleotide measurement | 2.15e-03 | 73 | 103 | 3 | EFO_0010513 | |
| Disease | BREAST CANCER | 2.43e-03 | 21 | 103 | 2 | 114480 | |
| Disease | Stomach Carcinoma | 2.43e-03 | 21 | 103 | 2 | C0699791 | |
| Disease | Mammary Carcinoma, Human | 2.47e-03 | 525 | 103 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.47e-03 | 525 | 103 | 7 | C1257931 | |
| Disease | Disproportionate short stature | 2.51e-03 | 77 | 103 | 3 | C0878659 | |
| Disease | Mammary Neoplasms | 2.53e-03 | 527 | 103 | 7 | C1458155 | |
| Disease | Esophageal Neoplasms | 2.60e-03 | 78 | 103 | 3 | C0014859 | |
| Disease | Malignant neoplasm of esophagus | 2.60e-03 | 78 | 103 | 3 | C0546837 | |
| Disease | electrocardiography | 2.61e-03 | 530 | 103 | 7 | EFO_0004327 | |
| Disease | Breast Carcinoma | 2.83e-03 | 538 | 103 | 7 | C0678222 | |
| Disease | Immunologic Deficiency Syndromes | 2.91e-03 | 23 | 103 | 2 | C0021051 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 2.91e-03 | 23 | 103 | 2 | OBA_2045158 | |
| Disease | mean platelet volume | PDS5B GLOD5 PCDHGB6 POLA1 UNC13D ITGA2 PLXND1 MAP4K5 SYNE2 CUX1 | 3.02e-03 | 1020 | 103 | 10 | EFO_0004584 |
| Disease | unipolar depression, response to selective serotonin reuptake inhibitor | 3.17e-03 | 24 | 103 | 2 | EFO_0003761, EFO_0005658 | |
| Disease | phosphatidylethanolamine measurement | 3.21e-03 | 173 | 103 | 4 | EFO_0010228 | |
| Disease | phosphatidylcholine measurement | 3.24e-03 | 284 | 103 | 5 | EFO_0010226 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DFHHAASKALRVPAE | 1361 | Q9HCE0 | |
| DIVFVLKDKPHAHFR | 241 | O75953 | |
| KPHFHGQAKEFSEHI | 2486 | Q68DQ2 | |
| DRFFEHEKAHENKPL | 231 | Q9BXI3 | |
| KFFKHFPELADSAIN | 51 | Q9BZZ5 | |
| LHPNTDPFKFEIHKQ | 611 | P55290 | |
| FAQQHKAKDPVALHE | 981 | Q5T5Y3 | |
| HAFNQSAELKPHVFE | 471 | Q6UXK2 | |
| IDPLFKHFHSVDIQA | 626 | P49792 | |
| AIAKFKEPAHALAFQ | 1136 | Q96EV2 | |
| KEPAHALAFQQKFHR | 1141 | Q96EV2 | |
| LHLASDFFLKHPDKD | 61 | Q9NTI5 | |
| IDPLFKHFHSVDIQA | 626 | Q99666 | |
| IDPLFKHFHSVDIQA | 626 | O14715 | |
| LREKKFDHHPQQFSS | 486 | Q02297 | |
| VNDHAPQFDKKEIHL | 126 | Q9Y5F9 | |
| KFQHPSHELLKENGF | 871 | Q6PKG0 | |
| VFDTGLSEKHPHFKN | 216 | Q14703 | |
| VKFNDQLISPKHFVH | 121 | Q9Y692 | |
| TKHFQRKAAHRDPVF | 1096 | Q8IWI9 | |
| FEDSPALKEHVFHNL | 716 | Q9Y4C4 | |
| SFLQKHADPLHDLSF | 1976 | Q8N201 | |
| NLHEVGKEFEPKAAH | 81 | A6NK44 | |
| PASVHFKADSVHFKG | 441 | Q13585 | |
| VHFKGDSVHFKPDSV | 451 | Q13585 | |
| KFADHLHKFHENDNG | 656 | Q13948 | |
| EHFFLHKEGISKDPS | 151 | P43629 | |
| LHLNEDFAKHTKFGN | 66 | P86397 | |
| AKEQHKLGFVSAFLH | 271 | Q9Y4D7 | |
| HLAKHFQVPVFKFVG | 471 | Q8WWZ8 | |
| KKDHEDFFTPQQHDK | 916 | O60245 | |
| FHNEVKAIGPHLAKD | 171 | O60437 | |
| KPAFVKADHADEVRF | 446 | Q6NT32 | |
| LDHPAIVKFHASFVE | 86 | Q8NG66 | |
| KHHVPSDFNVNVKVD | 216 | Q9C075 | |
| FTHQFFKTDHKRGPA | 191 | P35354 | |
| KPENKFHIKFADHVV | 421 | Q6UVM3 | |
| SFKPVMQKFLHDHVD | 811 | P78344 | |
| KTSHGHLIFPKQAFD | 411 | P17301 | |
| AALVHHSFALDKAAP | 561 | P09884 | |
| LSFHLHVAEPKAVFA | 1521 | Q5VST9 | |
| FFSKQLENNHVPKEH | 291 | Q96HP4 | |
| FHHESKENFALKTPL | 691 | O75330 | |
| FEAHKLKFNIPADQH | 316 | Q3SYC2 | |
| TFGAEVVAKFLHKHD | 226 | P62136 | |
| FFQSVPECEHHQKDK | 626 | Q13315 | |
| IFFDVKGHAHKATEA | 171 | Q9NZC3 | |
| FKAAAVPVEFQEHHL | 71 | O43837 | |
| INLLQDSKFHHFKPV | 646 | Q8N1I0 | |
| HQVPDDETIFKFKHA | 166 | O75319 | |
| PNFEPLHKFHTNFLK | 586 | Q9Y4F1 | |
| HRFNEGVHPAFALEK | 4036 | Q8N3K9 | |
| DLHAHKLRVDPVNFK | 86 | P69905 | |
| ADHFDHIKAVIGSKF | 331 | Q9H4A9 | |
| HEDHLEKVFDPKVFT | 736 | Q9Y4K1 | |
| DDPRKHHFFKTINFP | 446 | Q8WTQ7 | |
| PAAAVAQDHAKKFIA | 571 | D6RIA3 | |
| QHHAKPNIFHKDPDV | 221 | Q9Y5Q0 | |
| FHDQPHLKRKAFCSF | 111 | P01034 | |
| PFKKSFDVKHGVAHQ | 111 | C9J302 | |
| KEALDFHVDHQSRPF | 131 | Q9Y5B8 | |
| IFVLQKKHDFPVQAH | 91 | A0A1W2PPM1 | |
| FPKFQHPSHELLKEN | 691 | Q659C4 | |
| IALFEHAKKPGLAAH | 581 | Q9Y4K4 | |
| PLAAVADKFHQHAAA | 116 | O60422 | |
| PFVFQHHFPKQLAKA | 696 | Q8N2Y8 | |
| FSSPNVAKKFHVGHL | 131 | Q5T160 | |
| VKAFEKFHPNLLHQI | 41 | Q8WZA2 | |
| KEIFDFSPEEHLKHG | 3916 | Q8WXH0 | |
| HVGDHAEFVKNLLPK | 161 | Q15788 | |
| LLNFAAEHVPRAKHK | 156 | Q9Y227 | |
| PIRAFQKVFDEHKEH | 186 | A1L4K1 | |
| EKFLVFAHHKVVLDA | 726 | Q9NZC9 | |
| AAVDIVSHGKNHPFK | 61 | Q15319 | |
| QPQHKLEIFHPFFKD | 926 | Q9NRY4 | |
| STDDKHLKFQPHFGQ | 1081 | P25054 | |
| DLAFQVKEAHFKAHP | 251 | Q96RK0 | |
| IHKHGFFHRDLKPEN | 116 | Q9UPZ9 | |
| SVRKFLFPFHHTKAN | 121 | Q8IXR9 | |
| PVVKHVNPKASDAFH | 966 | O75153 | |
| EHFLDAQGHFVKPEA | 436 | A0A087X1C5 | |
| AHPSFHNINFKQAEK | 1331 | Q7KZ85 | |
| ALKVVAHNKFHDFAD | 471 | P48995 | |
| AASAPAEKHLHFVDV | 181 | Q6PCB0 | |
| AHKCPFAFQKDVHVP | 41 | Q8N6M9 | |
| KLPVVACFHFKRFEH | 301 | A6NNY8 | |
| HLFLEALKENFKVHP | 786 | Q5T7W0 | |
| ALKENFKVHPAHKVA | 791 | Q5T7W0 | |
| LTLVQDDKHFHKGFF | 411 | Q9C0E2 | |
| KAKFHAPSFHVDVPV | 591 | Q7Z392 | |
| AFSKDHQLLRADPKH | 326 | Q9UJT0 | |
| NFHRFAEKHNFAKPN | 61 | Q9NWX6 | |
| GAHLFPEKLEHFQEA | 701 | Q9NS62 | |
| KFLAEQFHLKHQFPS | 811 | Q86TI0 | |
| QHFAEAFKAKNVPLH | 191 | Q9NZC7 | |
| HKKLFSRHDPQAEEA | 436 | Q8WVM7 | |
| AFHPVSFPEEKAVHK | 176 | Q86YV5 | |
| TFGAEVVAKFLHKHD | 226 | P36873 | |
| APDHFQEDHLLQKEK | 3606 | Q96JG9 | |
| FHQDQKHHSAEKPLE | 136 | Q9BWM5 | |
| PFGHNFKETSDLIKH | 306 | Q8TF39 | |
| FHVAVNSFLEQHKPE | 196 | Q92889 | |
| EFHKHVEFDFLIKGQ | 46 | Q9GZL7 | |
| FVPKSHLFFTAGKDH | 641 | Q9UNX4 | |
| HLEKNHPEEFCEFVK | 66 | O96006 | |
| HQNDVKIPDAKHVFT | 196 | Q9BUB7 | |
| KSHLHPFKEAAQEVD | 696 | Q8IWU6 | |
| SIVPHVFKNKVGHFA | 376 | P51784 | |
| HKKDLHPLFDETFEF | 971 | Q70J99 | |
| EVHPKQHAFKQAFAK | 311 | Q6IBS0 | |
| HTFKGHKAEIHFLQP | 156 | Q8NI36 | |
| FLEALNSKLGKHAHF | 471 | O94832 |